Biotechnology Equipment Market Report 2026

Biotechnology Equipment Market Overview

• Biotechnology Equipment market size has reached to $74.83 billion in 2025 • Expected to grow to $157.49 billion in 2030 at a compound annual growth rate (CAGR) of 16% • Growth Driver: The Increasing Demand For Personalized Medicine Is Fueling The Market Growth Due To Advancements In Genetic And Molecular Profiling Technologies • Market Trend: Innovation In qPCR Systems Driving Advances In Genetic Analysis • North America was the largest region in 2025.

What Is Covered Under Biotechnology Equipment Market?

Biotechnology equipment refers to the specialized tools, instruments, and devices used to support and perform various biological and biochemical processes in research, development, and production within the biotechnology industry. These pieces of equipment facilitate activities such as genetic engineering, cell culture, molecular analysis, fermentation, and drug development. The main types of biotechnology equipment include lab automation instruments, life science consumables, in vitro diagnostics (IVD) instruments, medical lasers, and other products. Lab automation instruments are devices that streamline repetitive laboratory tasks to enhance efficiency, accuracy, and enable high-throughput processing. They are used in various applications such as life sciences, clinical diagnostics, quality management, and food and beverage testing. These instruments are utilized by a range of end-users, including pharmaceutical companies, government and academic institutions, hospitals and healthcare facilities, as well as other sectors.

What Is The Biotechnology Equipment Market Growth Forecast?

The biotechnology equipment market size is expected to see rapid growth in the next few years. It will grow to $157.49 billion in 2030 at a compound annual growth rate (CAGR) of 16.0%. The growth in the forecast period can be attributed to integration of ai and robotics in laboratories, rising pharmaceutical r&d investments, increasing adoption of high-throughput screening, expansion of genomics and precision medicine, advanced bioprocessing equipment utilization. Major trends in the forecast period include increased adoption of lab automation instruments, rising demand for life science consumables, expansion of in vitro diagnostics (ivd) applications, growing use of medical lasers in clinical procedures, rising investments in bioreactors, fermenters, and chromatography systems.

Global Biotechnology Equipment Market Segmentation

1) By Product: Lab Automation Instruments, Life Science Consumables, In Vitro Diagnostics (IVD) Instruments, Other Products 2) By Application: Life Science, Clinical Diagnostics, Quality Management, Food And Beverage Testing 3) By End-User: Pharmaceutical Companies, Government And Academic Institutions, Hospitals And Healthcare Facilities, Other End-Users Subsegments: 1) By Lab Automation Instruments: Liquid Handling Systems, Automated Microplate Handling Systems, Automated Sample Preparation Systems, Robotic Workstations, Automated Nucleic Acid Extraction Systems 2) By Life Science Consumables: Pipette Tips, Microplates And Polymerase Chain Reaction Plates, Cell Culture Products, Filtration Devices And Membranes, Reagents And Enzymes 3) By In Vitro Diagnostics (IVD) Instruments: Immunoassay Analyzers, Molecular Diagnostics Instruments, Hematology Analyzers, Clinical Chemistry Analyzers, Coagulation Analyzers 4) By Other Products: Bioreactors And Fermenters, Chromatography Systems, Spectroscopy Instruments, Centrifuges, Incubators And Ovens

What Is The Driver Of The Biotechnology Equipment Market?

The increasing demand for personalized medicine is expected to propel the growth of the biotechnology equipment market going forward. Personalized medicine involves tailoring medical treatment to individual characteristics, such as genetic makeup, lifestyle, and environment, to enhance treatment efficacy and reduce adverse effects. The increasing demand for personalized medicine is primarily due to advances in genetic and molecular profiling technologies that enable tailored treatments based on an individual’s unique biological makeup, improving efficacy and reducing side effects. Biotechnology equipment enables personalized medicine by providing precise tools for analyzing genetic and molecular data, allowing tailored treatments that improve patient outcomes and reduce adverse effects. For instance, in February 2024, Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized treatments for patients with rare diseases, marking a significant increase from the six approvals in 2022. Of these 2023 approvals, seven were cancer drugs, and three addressed other diseases and conditions. Therefore, the increasing demand for personalized medicine is driving the growth of the biotechnology equipment industry.

Key Players In The Global Biotechnology Equipment Market

Major companies operating in the biotechnology equipment market are Hoffmann La Roche Aktiengesellschaft, Thermo Fisher Scientific Inc, Danaher Corporation, Becton Dickinson and Company, Avantor Inc, Agilent Technologies Inc, Illumina Inc, Sartorius Aktiengesellschaft, PerkinElmer Inc, Mettler Toledo International Inc, Shimadzu Corporation, Waters Corporation, Bio Rad Laboratories Inc, Bruker Corporation, Buchi Labortechnik AG, Eppendorf SE, BioTek Instruments Inc, bioMerieux SA, Analytik Jena AG, Tecan Group AG

Global Biotechnology Equipment Market Trends and Insights

Major companies operating in the biotechnology equipment market are focusing on development of innovative systems such as qPCR systems to enhance accuracy, speed, and efficiency in genetic analysis. qPCR (quantitative polymerase chain reaction) systems are laboratory instruments used to amplify and simultaneously quantify targeted DNA or RNA molecules in real time; they help biotechnology by enabling precise gene expression analysis, mutation detection, and disease diagnostics, thereby accelerating research, clinical testing, and the development of targeted therapies. For instance, in September 2024, Takara Bio USA, Inc., s US-based manufacturing company, launched SmartChip ND Real-Time PCR System, a high-throughput, automated qPCR platform designed to advance broad surveillance of antimicrobial resistance through flexible, nanoliter-scale reactions and reduced hands-on time. This next-generation system supports high-throughput monitoring by enabling up to 5,184 nanoliter-scale reactions per chip, while requiring less than 30 minutes of hands-on time. The system eliminates the need for preamplification, reducing both reagent costs and experimental variability. With a compact design and flexible configuration options, the SmartChip ND system is particularly well-suited for environmental surveillance laboratories aiming to monitor large panels of AMR-related genes at low cost.

What Are Latest Mergers And Acquisitions In The Biotechnology Equipment Market?

In January 2024, Calibre Scientific, a US-based company specializing in manufacturing and supplying high-quality laboratory instruments, acquired Lab Tech S.r.l for an undisclosed amount. With this acquisition, Calibre Scientific aims to strengthen its position in the life sciences sector by expanding its portfolio of laboratory instruments and consumables. Lab Tech S.r.l is a UK-based company that manufactures biotechnology instruments such as centrifuges, shakers, incubators, and pipetting systems.

Regional Outlook

North America was the largest region in the biotechnology equipment market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Biotechnology Equipment Market?

The biotechnology equipment market includes sales of centrifuges, bioreactors, PCR machines, spectrophotometers, microscopes, chromatography systems, electrophoresis equipment, automated liquid handling systems, incubators, shakers, freeze dryers, microarray systems, and flow cytometers.Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.